Implementing neonatal screening for haemoglobinopathies in the Netherlands

Journal of Medical Screening

Volumn 17, Issue 2, 2010, Pages 58-65

  Bouva, Marelle J ^a   Mohrmann, Karin ^b   Brinkman, Henri B J M ^b   Kemper Proper, Evelien A ^a   Elvers, Bert ^b   Loeber, J Gerard ^a   Verheul, Francesco E A M ^b   Giordano, Piero C ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b IJSSELLAND HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HEMOGLOBINOPATHY; HUMAN; MALE; METHODOLOGY; NETHERLANDS; NEWBORN; NEWBORN SCREENING;

FEMALE; HEMOGLOBINOPATHIES; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NETHERLANDS;

EID: 77954936472     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2010.009075     Document Type: Article

References (27)

1. Steinberg MH. Pathophysiology of sickle cell disease. Baillieres Clin Haematol 1998;11:163-184
2. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 2008;86
3. Giordano PC, Harteveld CL, Heister AJ, et al. The molecular spectrum of beta-thalassemia and abnormal hemoglobins in the allochthonous and autochthonous dutch population. Community Genet 1998;1:243-251
4. Bardakdjian-Michau J, Bahuau M, Hurtrel D, et al. Neonatal screening for sickle cell disease in France. J Clin Pathol 2009;62:31-33
5. Streetly A, Latinovic R, Hall K, Henthorn J. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol 2009;62:26-30
6. Gulbis B, Cotton F, Ferster A, et al. Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol 2009;62:49-52
7. Lopez-Escribano H, Vila Vidal M, Barcelo Bennassar A, Riesco Prieto M, Ayllon Gatnau O. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population]. An Pediatr (Barc) 2009;70:429-433
8. Manu Pereira M, Corrons JL. Neonatal haemoglobinopathy screening in Spain. J Clin Pathol 2009;62:22-25
9. Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009;52:486-490
10. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest 2007;67:71-86
11. Rengelink-van der Lee JH, Schulpen TW, Beemer FA. [Incidence and prevalence of hemoglobinopathies in children in The Netherlands]. Ned Tijdschr Geneeskd 1995;139:1498-1501
12. Schulpen TW, van der Lee JH, van der Most van Spijk MW, Beemer FA. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune]. Ned Tijdschr Geneeskd 1998;142:1019-1022
13. Giordano PC, Bouva MJ, Harteveld CL. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in the Netherlands. Hemoglobin 2004;28:287-296
14. Health Council of the Netherlands. Neonatal Screening. The Hague: Health Council of the Netherlands, 2005; publication nol 2005/11. http://www. gezondheidsraad.nl/sites/default/files/05@11E.pdf
15. Campbell M, Henthorn JS, Davies SC. Evaluation of cation-exchange HPLC compared with isoelectric focusing for neonatal hemoglobinopathy screening. Clin Chem 1999;45:969-975
16. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000;95:360-362
17. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 2000;108:295-299
18. Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of alpha-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol 2003;74:99-103
19. Papadea C, Cate JCt. Identification and quantification of hemoglobins A, F, S, and C by automated chromatography. Clin Chem 1996;42:57-63
20. da Silva EM. Absence of sickling phenomenon of the red blood corpuscle among Brazilian Indians. Science 1948;107:221-222
21. Mantikou E, Arkesteijn SG, Beckhoven van JM, Kerkhoffs JL, Harteveld CL, Giordano PC. A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction. Clin Biochem 2009;42:1780-1785
22. Ou CN, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin Chim Acta 2001;313:187-194
23. Ou CN. Diagnosis of hemoglobinopathies by high-performance liquid chromatography. J Biomed Sci 1997;4:315-318
24. Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 2004;50:1736-1747
25. Fucharoen S, Winichagoon P, Wisedpanichkij R, et al. Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. Clin Chem 1998;44:740-748
26. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test 2001;5:93-100
27. Lanting CI, Rijpstra A, Breuning-Boers JM, Verkerk PH. [Evaluation of the neonatal heel prick screening of babies born in 2007]. Vol.: [Netherlands Organisation for Applied Scientific Research] TNO Kwaliteit van Leven, 2008